• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP Stewardship / Resistance Scan: Improper prescribing in kids; XDR Pseudomonas aeruginosa

Shiloh

Editor, Senior Moderator
Source: http://www.cidrap.umn.edu/news-perspective/2018/02/stewardship-resistance-scan-feb-23-2018


Stewardship / Resistance Scan for Feb 23, 2018
Improper prescribing in kids; XDR Pseudomonas aeruginosa

Filed Under:
Antimicrobial Stewardship

[h=3]Belgian study reports high rate of improper antibiotic prescribing in kids[/h] Belgian researchers report that almost a third of prescriptions for fluoroquinolones written for hospitalized children were deemed inappropriate, according to a study today in BMC Infectious Diseases.
The investigators analyzed data on all 262 fluoroquinolone prescriptions from 2010 through 2013 at two university children's hospitals. They then employed univariate and multivariate logistic regression models to analyze risk factors for inadequate dosing.
The team found that 79 prescriptions (30.2%) were inappropriate, with 57.0% of improper prescribing classified as underdiagnosing. Only 16.8% of the drugs were prescribed for labeled indications, and only 35.1% were guided by bacteriologic findings. Infants and older preschoolers were at particular risk for dosing errors.
The authors conclude, "[Fluoroquinolone] prescriptions for children should be improved by specific pediatric antimicrobial stewardship teams. Furthermore, pharmacokinetic studies should optimise dosing recommendations for children."
Feb 23 BMC Infect Dis study

[h=3]Researchers note high rate of extremely resistant Pseudomonas in Thailand[/h] Among 255 patients with Pseudomonas aeruginosa infections, 56 (22.0%) had extensively drug-resistant P aeruginosa (XDR-PA) and 32 (12.5%) had the multidrug-resistant (MDR-PA) form, scientists from Thailand announced yesterday in PLoS One.
The investigators retrospectively studied patients hospitalized with PA infections from April to December of 2014. The combined XDR-PA and MDR-PA total represents a 34.5% incidence of drug resistance. The researchers said that receiving total parenteral nutrition, prior carbapenem use, and prior fluoroquinolone use were all associated with a higher rate of XDR-PA. Factors associated with mortality among all patients were sepsis or septic shock, admission to a medical department, receiving a central venous catheter, and having an XDR-PA infection.
The authors reported that all XDR-PA infections remained susceptible to colistin. They conclude, "The prompt administration of an appropriate empirical antibiotic should be considered when an XDR-PA infection is suspected."
Feb 22 PLoS One study
 
Back
Top Bottom